Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.148 EUR | -0.06% |
|
+3.35% | +129.78% |
Jun. 25 | Moberg Pharma Raises SEK336 Million from Share Sale | MT |
May. 14 | Moberg Pharma AB Elects Jonas Ekblom as Board Member | CI |
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Ljung
CEO | Chief Executive Officer | 44 | 05-12-31 |
Mark Beveridge
DFI | Director of Finance/CFO | 46 | 14-12-31 |
Chief Tech/Sci/R&D Officer | 60 | 22-12-31 | |
Sales & Marketing | 62 | 19-01-07 | |
Annica Magnusson
LAW | General Counsel | 61 | 19-01-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Lundmark
BRD | Director/Board Member | 66 | 22-05-15 |
Håkan Wallin
BRD | Director/Board Member | 62 | 23-05-15 |
Nikolaj Sørensen
BRD | Director/Board Member | 52 | 20-12-31 |
Chairman | 64 | 22-05-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,407,452 | 19,561,311 ( 68.86 %) | 445,974 ( 1.570 %) | 68.86 % |
Company contact information
Moberg Pharma AB
Gustavslundsvägen 50 5th Floor
167 51, Bromma
+46 8 52 23 07 00
http://www.mobergderma.se![address Moberg Pharma AB(MB8)](https://cdn.zonebourse.com/static/address/45031904.png)
Group companies
Name | Category and Sector |
---|---|
Moberg Derma Incentives AB
| |
Pharmaceuticals: Major
|
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B |
- Stock Market
- Equities
- MOB Stock
- MB8 Stock
- Company Moberg Pharma AB